Panel Discussion: How Clinical Confidence & Scalability Shape the Future of CNS Drug Delivery
- Explore how investors evaluate risk and opportunity in a space where strong science must meet real-world viability
- Examine how clinical or translational validation – from receptor engagement to dose modeling – influences investor confidence in CNS delivery platforms
- Discuss how manufacturability, scalability, and delivery route compatibility affect long-term viability and funding decisions
- Understand the importance of mechanism clarity, receptor strategy, and IP positioning in shaping perceived value and freedom to operate